Femtobiomed Company Description

Femtobiomed Inc. engages in the development of cargo-free intracellular delivery platform.

The company, through its platform, CELLSHOT, is working on cell-based therapeutic pipelines. Its platform provides unprecedented approaches to cell therapeutics and cell biology research.

The company was founded in 2011 and is based in Seongnam-si, South Korea.

Femtobiomed Inc.

Country	South Korea
Founded	2011
Industry	Biological Products, Except Diagnostic Substances

Contact Details

Address: D-510, 700, Pangyo-ro Seongnam-si, 13516 South Korea
Phone	82 3 1628 8158
Website	femtobiomed.com

Stock Details

Ticker Symbol	327610
Exchange	Korea New Exchange
Reporting Currency	KRW
SIC Code	2836